The Cigna Group stock offers solid fundamentals but has regulatory risks. Learn why it's a Hold for now & discover key ...

Cigna trades at a significant discount to the S&P 500, offering a higher yield and faster dividend growth, making it ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...